Veeral Desai - Jul 21, 2022 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Strategy & Dev. Officer
Signature
/s/ Timothy Bensley, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Jul 21, 2022
Transactions value $
-$2,113,852
Form type
4
Date filed
7/25/2022, 04:16 PM
Previous filing
Jul 11, 2022
Next filing
Mar 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $79.8K +79.8K +28.67% $1.00* 358K Jul 21, 2022 Direct F1
transaction AGL Common Stock Sale -$2.19M -79.8K -22.28% $27.50 278K Jul 21, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -79.8K -58.14% $0.00 57.4K Jul 21, 2022 Common Stock 79.8K $1.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 These options were granted on April 27, 2017 and fully vested on April 27, 2021.